ライフサイエンスコーパス: nasopharyngeal carcinoma

1 ry leukoplakia) or latent infection (such as nasopharyngeal carcinoma).

2 epistaxis for 2 years and was diagnosed with nasopharyngeal carcinoma.

3 < .001) of this finding in the patients with nasopharyngeal carcinoma.

4 hought to be important to the development of nasopharyngeal carcinoma.

5 ality in 36% (11 of 31) of the patients with nasopharyngeal carcinoma.

6 is not found in EBV strains associated with nasopharyngeal carcinoma.

7 velopment of several malignancies, including nasopharyngeal carcinoma.

8 is the standard of care for locally advanced nasopharyngeal carcinoma.

9 ted with a variety of malignancies including nasopharyngeal carcinoma.

10 as the standard of care in locally advanced nasopharyngeal carcinoma.

11 ral forms of cancer, including lymphomas and nasopharyngeal carcinoma.

12 states exemplified by Burkitt's lymphoma and nasopharyngeal carcinoma.

13 cies Hodgkin and Burkitt lymphoma as well as nasopharyngeal carcinoma.

14 sociated tumors such as Burkitt lymphoma and nasopharyngeal carcinoma.

15 ents with hemophilia, autoimmune disease, or nasopharyngeal carcinoma.

16 th predisposition to autoimmune diseases and nasopharyngeal carcinoma.

17 val in patients with locoregionally advanced nasopharyngeal carcinoma.

18 as an aetiological factor in B lymphomas and nasopharyngeal carcinoma.

19 oth lymphoid and epithelial cells, including nasopharyngeal carcinoma.

20 e development of multiple cancers, including nasopharyngeal carcinoma.

21 showed that it improves overall survival in nasopharyngeal carcinoma.

22 as Burkitt and Hodgkin lymphoma, as well as nasopharyngeal carcinoma.

23 also causes nonlymphoid malignancies such as nasopharyngeal carcinoma.

24 a variety of ailments, from benign rashes to nasopharyngeal carcinoma.

25 580V, is associated with IgA nephropathy and nasopharyngeal carcinoma.

26 transplant lymphoproliferative disorder, and nasopharyngeal carcinoma.

27 event or enhance treatment of EBV-associated nasopharyngeal carcinoma.

28 with the development of B cell lymphomas and nasopharyngeal carcinomas.

29 viral reactivation occurs in EBV-associated nasopharyngeal carcinomas.

30 cell lines from patients with EBV-associated nasopharyngeal carcinoma (3 out of 22, P = 0.0003), wher

31 ated recent trends in the incidence rates of nasopharyngeal carcinoma among Chinese living in Los Ang

32 LMP2 transcripts are detected in nasopharyngeal carcinoma, an epithelial-cell malignancy.

33 expressed in the EBV-associated malignancies nasopharyngeal carcinoma and Burkitt's lymphoma, and are

34 ted with several types of cancers, including nasopharyngeal carcinoma and Burkitt's lymphoma.

35 e protein 1 (LMP1) gene has been reported in nasopharyngeal carcinoma and EBV-associated malignant ly

36 n the EBV-associated epithelial malignancies nasopharyngeal carcinoma and gastric carcinoma, and thes

37 d association with the epithelial malignancy nasopharyngeal carcinoma and has also been reported in o

38 ithin the terminal repeats is active in both nasopharyngeal carcinoma and Hodgkin's disease tissues.

39 pattern is typical of EBV gene expression in nasopharyngeal carcinoma and Hodgkin's disease, and diff

40 essed in primary biopsies from patients with nasopharyngeal carcinoma and Hodgkin's disease, where LM

41 munotherapeutic strategies to tumors such as nasopharyngeal carcinoma and Hodgkin's lymphoma that hav

42 L1-TR, active in nasopharyngeal carcinoma and Hodgkin's lymphoma, is loca

43 ears; age range, 27-68 years) with untreated nasopharyngeal carcinoma and in 31 control subjects (17

44 EBV) LMP1 protein is frequently expressed in nasopharyngeal carcinoma and is essential for the transf

45 ially has classified formaldehyde as causing nasopharyngeal carcinoma and myeloid leukemia.

46 chemotherapy in patients with non-metastatic nasopharyngeal carcinoma and obtained updated data for p

47 y in certain epithelial pathologies, such as nasopharyngeal carcinoma and oral hairy leukoplakia, ind

48 in-Barr virus (EBV)-associated malignancies, nasopharyngeal carcinoma and posttransplant lymphoma, ra

49 iously reported isolates from EBV-associated nasopharyngeal carcinomas and Burkitt's lymphomas occurr

50 produced complete remissions of EBV-positive nasopharyngeal carcinomas and lymphomas developing in im

51 posttransplant lymphomas, Hodgkin's disease, nasopharyngeal carcinoma, and AIDS-related lymphomas.

52 several malignancies as Burkitt's lymphoma, nasopharyngeal carcinoma, and Hodgkin's disease.

53 ncer tissues, such as large B cell lymphoma, nasopharyngeal carcinoma, and melanoma.

54 nt in Burkitt's lymphoma, Hodgkin's disease, nasopharyngeal carcinoma, and nasal lymphoma.

55 pment of Burkitt lymphoma, Hodgkin lymphoma, nasopharyngeal carcinoma, and other EBV-associated disea

56 onsistently been associated with the risk of nasopharyngeal carcinoma, and patients with Hodgkin lymp

57 rasts with EBV-associated Hodgkin's disease, nasopharyngeal carcinoma, and post-transplant lymphoprol

58 ithelial cells derived from gastric cancers, nasopharyngeal carcinomas, and normal oral keratinocytes

59 hlights recent advances in the management of nasopharyngeal carcinoma as a result of these endeavors.

60 ssociated with epithelial cell malignancies (nasopharyngeal carcinoma) as well as B-cell malignancies

61 of an EBV-based screening strategy to detect nasopharyngeal carcinoma at early stages and hopefully r

62 primary EBV-positive Hodgkin's lymphoma and nasopharyngeal carcinoma biopsies correlates with the nu

63 a herpesvirus linked to malignancies such as nasopharyngeal carcinoma, Burkitt's lymphoma, and Hodgki

64 (37 of 62 subjects) among the patients with nasopharyngeal carcinoma but only 3% (two of 62 subjects

65 This resembles the N classification of nasopharyngeal carcinoma but without a lower neck lymph

66 therapy in the treatment of locally advanced nasopharyngeal carcinoma, but its reproducibility was un

67 ove the outcomes for locoregionally advanced nasopharyngeal carcinoma by testing the feasibility and

68 he cell cycle, was consistently expressed in nasopharyngeal carcinomas by immunohistochemical analysi

69 iR-BART6 found in Daudi Burkitt lymphoma and nasopharyngeal carcinoma C666-1 cell lines suppressed pr

70 on in epithelial cells (including the C666-1 nasopharyngeal carcinoma cell line), although Na does no

71 ellular carcinoma cell line, and KB, a human nasopharyngeal carcinoma cell line.

72 originally reported but also in a number of nasopharyngeal carcinoma cell lines and a gastric carcin

73 Nasopharyngeal carcinoma cell lines constitutively expre

74 lytic viral gene expression in EBV-positive nasopharyngeal carcinoma cells and lymphoblastoid cells,

75 llular accumulation of HIF-1alpha of hypoxic nasopharyngeal carcinoma cells and mediates the radiatio

76 Exosomes produced by EBV-infected nasopharyngeal carcinoma cells contain high levels of th

77 s type I interferon production, and in human nasopharyngeal carcinoma cells results in almost complet

78 ter in CTAR1-expressing epithelial cells and nasopharyngeal carcinoma cells.

79 has been shown to mediate chemomigration in nasopharyngeal carcinoma cells.

80 s the radiation-resistant phenotype of these nasopharyngeal carcinoma cells.

81 4 X 10(6) folate-receptor-positive KB (human nasopharyngeal carcinoma) cells into athymic mice yielde

82 izing action on KBvin (vincristine-resistant nasopharyngeal carcinoma) cells, a multidrug resistant c

83 + cells from the two donor groups, KB (human nasopharyngeal carcinoma) cells, and M07e (human megakar

84 8 x 10(6) folate receptor-positive KB (human nasopharyngeal carcinoma) cells, yielding 0.2- to 0.6-g

85 ts, and arrested cells at the G0/G1 phase in nasopharyngeal carcinoma CNE-2Z cells.

86 We further demonstrate in nasopharyngeal carcinoma CNE2 and 5-8F cells that this c

87 ts in the hypoxic regions of tumor formed by nasopharyngeal carcinoma CNE2 cells and breast cancer MD

88 er B-cell lymphoma-, gastric carcinoma-, and nasopharyngeal carcinoma-derived cell lines.

89 ients older than 18 years with stage IIB-IVB nasopharyngeal carcinoma from 19 centres in North Americ

90 ogies ranging from oral hairy leukoplakia to nasopharyngeal carcinoma, from infectious mononucleosis

91 he development of various cancers, including nasopharyngeal carcinoma, gastric cancer, Burkitt lympho

92 previously in EBV-associated tumors such as nasopharyngeal carcinoma, Hodgkin's disease (HD), and T/

93 may have implications for the development of nasopharyngeal carcinoma in high-risk populations in whi

94 From 1992 to 2002, the rates of nasopharyngeal carcinoma in these two populations decrea

95 However, since the 1980s, nasopharyngeal carcinoma incidence has fallen among both

96 Sixteen patients with nasopharyngeal carcinoma initially treated with 50.0-88.

97 Nasopharyngeal carcinoma is a major cancer that develops

98 Nasopharyngeal carcinoma is a malignancy that is prevale

99 Nasopharyngeal carcinoma is a rarely seen tumor in child

100 d chemoradiation treatment for patients with nasopharyngeal carcinoma is feasible, and might delay th

101 Nasopharyngeal carcinoma is much more common in Asian co

102 V) is invariably present in undifferentiated nasopharyngeal carcinomas, is found sporadically in othe

103 Nasopharyngeal carcinoma, Kaposi's sarcoma, and B-cell l

104 analysis of global gene expression in human nasopharyngeal carcinoma KB cells grown in folate-deplet

105 of all compounds were tested versus a human nasopharyngeal carcinoma (KB) cell line to enable an est

106 ked to the development of cancers, including nasopharyngeal carcinoma, lymphomas, and gastric cancer.

107 man malignancies including Burkitt lymphoma, nasopharyngeal carcinoma, lymphoproliferative disease an

108 related central nervous system lymphomas and nasopharyngeal carcinomas) may allow novel, EBV-based ta

109 in about half of the patients with untreated nasopharyngeal carcinoma, may reflect tumor proximity to

110 ein 1 (LMP1), is detected in at least 70% of nasopharyngeal carcinoma (NPC) and all EBV-infected prei

111 U, expression is frequently downregulated in nasopharyngeal carcinoma (NPC) and many other tumors due

112 urrently involved in structural variation in nasopharyngeal carcinoma (NPC) and the identification of

113 Incidence rates of nasopharyngeal carcinoma (NPC) are much higher among Chi

114 stablished epithelial cell lines and primary nasopharyngeal carcinoma (NPC) biopsy specimens.

115 Nasopharyngeal carcinoma (NPC) cell lines are important

116 In this study, using nasopharyngeal carcinoma (NPC) cells as a model system,

117 g Burkitt's lymphoma Rael cells and cultured nasopharyngeal carcinoma (NPC) cells contained nuclear S

118 In this study, exosomes released from nasopharyngeal carcinoma (NPC) cells harboring latent EB

119 ypes, including Burkitt lymphoma (BL) cells, nasopharyngeal carcinoma (NPC) cells, and lymphoblastoid

120 are constitutively activated and nuclear in nasopharyngeal carcinoma (NPC) cells.

121 ted tumors such as Hodgkin lymphoma (HL) and nasopharyngeal carcinoma (NPC) express FasL, we determin

122 Conventional treatment for nasopharyngeal carcinoma (NPC) frequently fails and is a

123 Undifferentiated nasopharyngeal carcinoma (NPC) has a 100% association wi

124 al T lymphocyte infiltrate found in cases of nasopharyngeal carcinoma (NPC) has been implicated in th

125 Nasopharyngeal carcinoma (NPC) has extremely skewed ethn

126 er, the role of Met/HGF signaling pathway in nasopharyngeal carcinoma (NPC) has not been evaluated.

127 Nonkeratinizing nasopharyngeal carcinoma (NPC) is 100% associated with E

128 The epithelial-derived nasopharyngeal carcinoma (NPC) is a rare tumor in most o

129 Nasopharyngeal carcinoma (NPC) is a unique epithelial ma

130 Nasopharyngeal carcinoma (NPC) is an aggressive head and

131 Nasopharyngeal carcinoma (NPC) is an EBV-associated epit

132 Nasopharyngeal carcinoma (NPC) is an endemic cancer in s

133 Undifferentiated nasopharyngeal carcinoma (NPC) is an epithelial malignan

134 Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus

135 Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus-

136 Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus-

137 Nasopharyngeal carcinoma (NPC) is an invasive cancer wit

138 Nasopharyngeal carcinoma (NPC) is associated with EBV in

139 Radioresistance of EBV-associated nasopharyngeal carcinoma (NPC) is associated with poor p

140 Nasopharyngeal carcinoma (NPC) is characteristic for its

141 Nasopharyngeal carcinoma (NPC) is closely associated wit

142 Nasopharyngeal carcinoma (NPC) is endemic in China and S

143 reatment of EBV-associated cancer.IMPORTANCE Nasopharyngeal carcinoma (NPC) is highly associated with

144 Undifferentiated nasopharyngeal carcinoma (NPC) is latently infected with

145 Nasopharyngeal carcinoma (NPC) is the most frequent Epst

146 Nasopharyngeal carcinoma (NPC) is universally associated

147 l OPC regional lymph node (N) categories and nasopharyngeal carcinoma (NPC) N categories.

148 Given salvage treatment for recurrent nasopharyngeal carcinoma (NPC) remains a clinical dilemm

149 de polymorphisms (SNPs) in PIN1 promoter and nasopharyngeal carcinoma (NPC) risk with a small sample

150 frequently present in Chinese and Indonesian nasopharyngeal carcinoma (NPC) samples.

151 fragment have been previously identified in nasopharyngeal carcinoma (NPC) tissues.

152 the expression of MMP-2, MMP-9, and VEGF in nasopharyngeal carcinoma (NPC) tumors by using three NPC

153 mprehensive profile of EBV miRNAs in primary nasopharyngeal carcinoma (NPC) tumors including estimate

154 sine (cidofovir) on the EBV-associated tumor nasopharyngeal carcinoma (NPC) was evaluated in NPC xeno

155 eatment of Epstein-Barr virus (EBV)-positive nasopharyngeal carcinoma (NPC) with EBV-specific cytotox

156 also elevated in the LMP1-expressing tumor, nasopharyngeal carcinoma (NPC), a highly invasive neopla

157 n EBV-transformed lymphoblastoid cell lines, nasopharyngeal carcinoma (NPC), a subset of Hodgkin's di

158 Nasopharyngeal carcinoma (NPC), an EBV-associated malign

159 ansplant lymphoproliferative disease (PTLD), nasopharyngeal carcinoma (NPC), and AIDS-associated lymp

160 B cell lymphomas, Hodgkin's disease (HD) and nasopharyngeal carcinoma (NPC), and by its unique abilit

161 's lymphoma, diffuse large B-cell lymphomas, nasopharyngeal carcinoma (NPC), and lymphomas that devel

162 g tumors that have latent infection, such as nasopharyngeal carcinoma (NPC), and oral hairy leukoplak

163 BV is associated with the epithelial cancer, nasopharyngeal carcinoma (NPC), and the lymphoid maligna

164 survival rates in cancer patients, including nasopharyngeal carcinoma (NPC), breast cancer and hepato

165 tumor burden and prognosis in patients with nasopharyngeal carcinoma (NPC), but data on the relation

166 cellular differentiation is a key feature of nasopharyngeal carcinoma (NPC), but it also presents as

167 ly linked with human B-cell malignancies and nasopharyngeal carcinoma (NPC), establishes three types

168 associated with many human cancers, such as nasopharyngeal carcinoma (NPC), Hodgkin's disease, and g

169 n-Barr virus (EBV), aetiologically linked to nasopharyngeal carcinoma (NPC), is the first human virus

170 the one viral protein uniformly expressed in nasopharyngeal carcinoma (NPC), represents a prime targe

171 In the EBV-associated epithelial tumor nasopharyngeal carcinoma (NPC), the virus-encoded latent

172 Nasopharyngeal carcinoma (NPC), which is closely associa

173 perties in EBV-associated cancers, including nasopharyngeal carcinoma (NPC).

174 disease, and Burkitt's lymphoma, as well as nasopharyngeal carcinoma (NPC).

175 nancies, including the epithelial malignancy nasopharyngeal carcinoma (NPC).

176 lymphoid and epithelial malignancies such as nasopharyngeal carcinoma (NPC).

177 expressed in the EBV associated malignancy, nasopharyngeal carcinoma (NPC).

178 velopment of CD44(+/High) stem-like cells in nasopharyngeal carcinoma (NPC).

179 in-Barr virus (EBV) to the aggressiveness of nasopharyngeal carcinoma (NPC).

180 ethylation are hallmarks of undifferentiated nasopharyngeal carcinoma (NPC).

181 an oncogene in epithelial carcinomas such as nasopharyngeal carcinoma (NPC).

182 ssion of the highly invasive EBV malignancy, nasopharyngeal carcinoma (NPC).

183 target to improve the therapeutic regimen of nasopharyngeal carcinoma (NPC).

184 ssociated with epithelial cancers, including nasopharyngeal carcinoma (NPC).

185 uding Burkitt lymphoma, Hodgkin disease, and nasopharyngeal carcinoma (NPC).

186 both lymphoid and epithelial cells including nasopharyngeal carcinoma (NPC).

187 in-Barr virus and is frequently expressed in nasopharyngeal carcinoma (NPC).

188 Radiotherapy is the standard therapy for nasopharyngeal carcinoma (NPC); however, radioresistance

189 es, including virtually all undifferentiated nasopharyngeal carcinomas (NPC) and a portion of gastric

190 Nonkeratinizing nasopharyngeal carcinomas (NPC) are >95% associated with

191 sion between 31 laser-capture-microdissected nasopharyngeal carcinomas (NPCs) and 10 normal healthy n

192 Undifferentiated nasopharyngeal carcinomas (NPCs) are commonly present wi

193 n abundance between blood and throat washes, nasopharyngeal carcinomas (NPCs) from areas of endemicit

194 to explore infectious agents associated with nasopharyngeal carcinomas (NPCs), we employed our high-t

195 for an increased hazard of myeloid leukemia, nasopharyngeal carcinoma, or other upper airway tumors f

196 e effective in the treatment of EBV-positive nasopharyngeal carcinomas passaged in nude mice than eit

197 therefore subjected to negative selection in nasopharyngeal carcinoma pathogenesis.

198 ponses were rescued in approximately half of nasopharyngeal carcinoma patients by peptide and cytokin

199 MATERIAL/METHODS: The study included 10 nasopharyngeal carcinoma patients under the age of 18 ye

200 or antigen has been significantly altered in nasopharyngeal carcinoma patients.

201 has been found in infectious mononucleosis, nasopharyngeal carcinoma, posttransplant lymphoma, and n

202 plication of BRISK to archival tissue from a nasopharyngeal carcinoma resulted in identification of E

203 parts of its sequences have been reported as nasopharyngeal carcinoma susceptibility protein and medu

204 , solid tumors such as renal cell carcinoma, nasopharyngeal carcinoma, thymic carcinoma, meduloblasto

205 Immunohistochemical analyses of nasopharyngeal carcinoma tumors revealed that STAT3, STA

206 enically conserved among virus isolates from nasopharyngeal carcinoma tumors.

207 In the current study, 59 cases of nasopharyngeal carcinoma were evaluated for expression o

208 rican Joint Committee on Cancer stage II-IVb nasopharyngeal carcinoma were treated with 70-Gy concomi

209 actionated radiotherapy, or including mostly nasopharyngeal carcinomas were excluded.

210 originally identified in cDNA libraries from nasopharyngeal carcinoma, where they are expressed at hi